ORCHESTRA BIOMED HOLDINGS IN (OBIO) Stock News

NASDAQ:OBIO - US68572M1062 - Common Stock

2.73 USD

+0.02 (+0.74%)

Last: 8/29/2025, 8:00:02 PM

2.77 USD

+0.04 (+1.47%)

After Hours: 8/29/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

OBIO Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Benzinga - Mentions: EPIX WORX THAR NLSP ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

6 days ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology

6 days ago - By: Orchestra BioMed Holdings, Inc. - Mentions: MDT

Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology

12 days ago - By: Benzinga - Mentions: AMAT AGL GIS GT

This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

18 days ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction

18 days ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction

20 days ago - By: Zacks Investment Research - Mentions: GBIO

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates

20 days ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates

20 days ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates

24 days ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility

24 days ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility

a month ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings

a month ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings

a month ago - By: Zacks Investment Research - Mentions: CRSP

CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Lags Revenue Estimates

a month ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Pricing of $40 Million Public Offering

a month ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Pricing of $40 Million Public Offering

a month ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Proposed Public Offering

a month ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Proposed Public Offering

a month ago - By: Orchestra BioMed Holdings, Inc. - Mentions: LGND MDT

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

a month ago - By: Orchestra BioMed Holdings, Inc.

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

3 months ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025

3 months ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025

3 months ago - By: ACCESS Newswire - Mentions: ULY HTCR DGXX LWLG ...

Sidoti Events, LLC's Virtual May Micro-Cap Conference

4 months ago - By: Zacks Investment Research - Mentions: IGMS

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates

4 months ago - By: Orchestra BioMed Holdings, Inc. - Mentions: MDT

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

4 months ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

4 months ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure

4 months ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure

4 months ago - By: Zacks Investment Research - Mentions: RARE

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

4 months ago - By: Zacks Investment Research - Mentions: NTLA

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

4 months ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

4 months ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

4 months ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

4 months ago - By: Orchestra BioMed Holdings, Inc. - Mentions: MDT

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

4 months ago - By: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting